2.57
Precedente Chiudi:
$2.64
Aprire:
$2.6
Volume 24 ore:
21,789
Relative Volume:
0.03
Capitalizzazione di mercato:
$3.69M
Reddito:
$1.03M
Utile/perdita netta:
$-11.10M
Rapporto P/E:
-0.0389
EPS:
-66.0832
Flusso di cassa netto:
$-8.21M
1 W Prestazione:
-7.89%
1M Prestazione:
-14.90%
6M Prestazione:
-79.27%
1 anno Prestazione:
-93.51%
Ispecimen Inc Stock (ISPC) Company Profile
Nome
Ispecimen Inc
Settore
Industria
Telefono
781-301-6700
Indirizzo
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, NTRA, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ISPC
Ispecimen Inc
|
2.57 | 3.81M | 1.03M | -11.10M | -8.21M | -66.08 |
|
TMO
Thermo Fisher Scientific Inc
|
517.60 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
193.62 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
564.98 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
283.80 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
WAT
Waters Corp
|
378.89 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Ispecimen Inc Borsa (ISPC) Ultime notizie
iSpecimen Company Profile & Introduction - Moomoo
Price to sales forward of iSpecimen Inc. – NASDAQ:ISPC - TradingView
Price to book forward of iSpecimen Inc. – NASDAQ:ISPC - TradingView
Price to earnings forward of iSpecimen Inc. – NASDAQ:ISPC - TradingView
iSpecimen (ISPC) Slips 4% as Stock Tests Key Support Near $2.44Revenue Growth Stocks - dars.gov.et
iSpecimen Inc Actuals & Estimates (NASDAQ:ISPC) - TradingView
ISpecimen Offering Up to 1.54M Shrs - Moomoo
iSpecimen (NASDAQ: ISPC) plans $4M common stock and pre-funded warrant sale - Stock Titan
iSpecimen Inc (ISPC) Institutional Confidence - TradingKey
iSpecimen Stockweekly review and sector backdrop - AD HOC NEWS
ISPC Should I Buy - Intellectia AI
iSpecimen | 8-K: Current report - Moomoo
iSpecimen Inc (ISPC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
iSpecimen Inc (ISPC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
iSpecimen Inc (ISPC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
iSpecimen Inc (ISPC) Valuation: PE, PB & Fair Value Analysis - TradingKey
[EFFECT] iSpecimen Inc. SEC Filing - Stock Titan
iSpecimen Inc (ISPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
iSpecimen Inc (ISPC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iSpecimen Inc (ISPC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
iSpecimen Receives Nasdaq Noncompliance Notice, Listing at Risk - TipRanks
iSpecimen Q3 2024 Earnings: Significant EPS Miss Amidst Limited Financial DisclosureEarnings Miss Streak - newsline.com
iSpecimen Inc Stock (US46536T1016): shares in focus after quiet session - AD HOC NEWS
ISPC Q3 2024 Earnings: Massive EPS Miss with 983.59% Negative SurpriseStrong Earnings Momentum - newsline.com
ISPC Q3 2024 Earnings: Widely Missed EPS Expectations, Stock Rises 6%Earnings Call Q&A - newsline.com
iSpecimen (NASDAQ: ISPC) registers 488,290 shares from May 2026 placement - Stock Titan
MSN Money - MSN
$iSpecimen (ISPC.US)$ so far so good - Moomoo
iSpecimen Inc. Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Emerging Growth Status (May 29, 2026) - Minichart
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (NASDAQ: ISPC) falls below Nasdaq equity listing requirement - Stock Titan
iSpecimen Inc. Files Form 8-K Announcing Approval of 2025 Stock Incentive Plan and Key Company Details - Minichart
iSpecimen Shareholders Approve Director, Auditor and Incentive Plan - The Globe and Mail
What's Driving iSpecimen's Recent Stock Surge - Kavout
iSpecimen (ISPC) investors approve director, auditor and 2025 stock incentive plan - Stock Titan
iSpecimen Inc.Common Stock (Nasdaq:ISPC) Stock Quote - FinancialContent
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Massive EPS Miss Reflects Operational ChallengesSegment Revenue Breakdown - The Legal Advocate
iSpecimen trades near lows as cash test and vote loom - Bez Kabli
iSpecimen Inc. (ISPC) Holds Steady Near Key Support as Sector Headwinds LingerMean Reversion Trade - The Legal Advocate
ISPC Q3 2024 Earnings: EPS Misses Estimates Sharply Amid Operational UncertaintiesEarnings Trend Analysis - dars.gov.et
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Significant EPS Miss Amidst Operational ChallengesHigh Growth Earnings - newsline.com
iSpecimen Inc. (ISPC) Slips 2% as Stock Tests Support Near $3.21Fast Moving Stocks - The Legal Advocate
ISPCiSpecimen Inc Stock Price and Quote - Finviz
iSpecimen Inc (ISPC) Stock Price, Quote, News & History - Benzinga
iSpecimen (ISPC) Faces Renewed Selling Pressure, Tests Key Support Near $3.28Safe Entry Stocks - newsline.com
iSpecimen stock (US46536T1016): Company update still needs a dated catalyst - AD HOC NEWS
iSpecimen Inc stock (US46536T1016): Clinical sample platform faces a fresh investor spotlight - AD HOC NEWS
iSpecimen Inc. Q1 2026 10-Q Report: Financial Performance, Going Concern, and Reverse Stock Split Overview - Minichart
iSpecimen Inc. 1Q 2026: Revenue $156.01K, EPS ($6.66) — 10-Q Summary - TradingView
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Ispecimen Inc Azioni (ISPC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):